Upcoming Conferences

4th Annual MarketsandMarkets High Potent Medicines Conference

4th Annual MarketsandMarkets High Potent Medicines Conference
21st - 22nd September 2020 London, UK

The cytotoxic nature of HPAPIs presents significant handling challenges and thus requires heavy investments for implementing specialized containment facilities that facilitate the safety of employees from exposure. Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. 

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

MarketsandMarkets is proud to announce the 4th Annual High Potent Medicines Conference to be held on 21st - 22nd September 2020 in London, UK. This conference would address the challenges in the continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.


2nd Annual MarketsandMarkets Industry 4.0 Conference

2nd Annual MarketsandMarkets Industry 4.0 Conference
22 - 23 September 2020 Chicago, USA

Industry 4.0 influences mission-critical applications in business processes and the manufacturing companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, which goes a long way with customers. This has made the revolution as the need of hour!

The successful inaugural event of MarketsandMarkets Industry 4.0 Conference-Chicago, focused on the impact of IIOT and Cybersecurity, by addressing a series of application-based illustrations and discussions to map the future possibility of trends in the manufacturing world.

Click here to see the post show report of the inaugural event.


MarketsandMarkets Big Data Analytics & Real Time Decision Making

MarketsandMarkets Big Data Analytics & Real Time Decision Making
September 22 - 23, 2020 Chicago, USA

Data analytics in the past decade has proven to be a breakthrough for various applications of data science to enhance profits and to win over competition. Industries such as healthcare, banking and finance have harnessed data to identify new opportunities thereby creating successful commercial case studies which allow experts to take the right decisions at the right time to achieve maximum return on investments and efficient operations.


2nd Annual MarketsandMarkets Chief Strategy Officer Forum

2nd Annual MarketsandMarkets Chief Strategy Officer Forum
September 24-25, 2020 New York

In a constantly evolving innovative time, companies continue to wrestle for deriving more value from their “business and corporate strategies”. The significance of a business strategy relies on it being a viable way to build up business desires, creating a competitive advantage and additionally increment shareholder value to something beyond the aggregate of its physical resources. MarketsandMarkets Chief Strategy Officer Forum invites leading strategy decision makers who are making the future.


MarketsandMarkets Advanced Diagnostics Series

MarketsandMarkets Advanced Diagnostics Series
5-6 October 2020 London - UK

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised and accurate.

In the era of improved diagnostics, our inaugural MarketsandMarkets Advanced Diagnostics Series that is scheduled to be held on 5-6 October, 2020, in London - UK, will serve as a networking place for Diagnostics professional, Industrial specialists, and solution providers to address the rising innovation in its discipline and the way it can be used as disease prevention tool.


3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
22- 23 October, 2020 Boston, MA

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on October 22-23, 2020 in Boston, USA.

While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.

Click here to see the post-show report of our 2nd Edition of the congress.


5th Annual MarketsandMarkets Infection Control, Sterilization and Decontamination in Healthcare Congress

5th Annual MarketsandMarkets Infection Control, Sterilization and Decontamination in Healthcare Congress
22nd - 23rd October 2020 Millennium Gloucester Hotel London Kensington

Around 1 in 20 (6%) of patients are affected by preventable harm in medical care, of which around 12% causes permanent disability or death, according to a study published by The BMJ. These infections are contracted by an estimated 1.7 million patients annually and responsible for 99,000 deaths each year.

Preventing disease and controlling spread of resistant bacteria is of major importance when tackling antibiotic resistance.  Already, AMR infections are estimated to cause 700,000 deaths each year globally, which is predicted to rise to 10 million, alongside a cumulative cost of $100 trillion, by 2020 if no action is taken.


4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
29th - 30th October, 2020 ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD

In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.


4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress
29th - 30th October 2020 ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD

Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.


MarketsandMarkets MarTech Innovation & Leadership Summit

MarketsandMarkets MarTech Innovation & Leadership Summit
5th - 6th November 2020 Millennium Gloucester Hotel London Kensington

Where does your success begin? With constant development emerging in global marketing scenario, things have become far more complicated then it seems. Smarter marketing solutions opted by the Chief Marketing professionals give the holistic view over the depth of any industry, economically and ideologically. These solutions help organizations improve their measurement and strategic planning. Smarter the solutions, better the outcomes.


MarketasndMarkets DigiIoMT & MedTech Summit

MarketasndMarkets DigiIoMT & MedTech Summit
10 - 11 November 2020

The world health is taking a new leap and is being re-structured with multiple technological pillars viz MedTech, Robotic surgery, Artificial Intelligence, TeleHealth, IoMT, Blockchain adding on to many more. Get addressed to challenges like remote patient monitoring, data management, long gestation period, new technology adaption & tedious regulatory hurdles by applying these technologies to make things easier.